The Street’s Key Stock Analysts Research Reports
$CSII, $CTL, $ITRI, $FNST, $LH, $LSTR, $MELI, $NFLX, $NITE, $YRCW
Daily HeffX-LTN reviews dozens of the Street’s Key analysts research reports to ID new tradingand investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.
Below is a list of the Street’s Key analysts outlook for main issues for Thursday, as follows:
Cardiovascular Systems Inc. (NASDAQ:CSII) was started with a Buy rating and assigned a 45 price target at Stifel.
CenturyLink Inc. (NYSE:CTL) was downgraded to Sell from Neutral with a 19 price target at MoffattNathanson. Its consensus target price was 21.28, and it has a 52-wk trading range of 13.16 to 24.20.
Itron Inc. (NASDAQ:ITRI) was raised to Buy from Hold with a 72 price target at Argus.
Finisar Inc. (NASDAQ:FNSR) was downgraded to Market Perform from Outperform at Raymond James.
Laboratory Corp. of America Holdings (NYSE:LH) was reiterated as Buy with a target price of 202 at Argus.
Landstar Systems Inc. (NASDAQ: LSTR) was raised to Outperform from Market Perform with a 133 price target at Wells Fargo.
MercadoLibre Inc. (NASDAQ: MELI) was raised to Buy from Hold with a 380 price target at Stifel.
Netflix Inc. (NASDAQ:NFLX) was reiterated as Buy and the price target was raised to 395 from 390 at MKM Partners. The team is calling for 90-M US subscribers and 300-M international subscribers by Y 2025.
Nightstar Therapeutics PLC (NASDAQ:NITE) was started with a Buy rating and assigned a 34 price target at Janney. The firm called Nightstar a leader in gene therapy for inherited retinal disorders.
YRC Worldwide Inc. (NASDAQ: YRCW) was raised to Buy from Hold at Deutsche Bank. The 52-wk trading range is 8.07 – 17.61
Latest posts by Paul Ebeling (see all)
- Wall Street’s Key Stock Analysts Research Reports - January 17, 2020
- After You Have Seen Paris… - January 16, 2020
- Opioid Crisis: a Perfect Storm of Poverty, Trauma, Availability and Pain - January 16, 2020